## GEV: GE Vernova Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.5% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($592.91)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Electrifying the Future: A Deep-Dive Into GE Vernova (GEV)**
- Source: FinancialContent | 20251223T102000 | Bullish | Relevance: 100%
- This article provides a comprehensive deep-dive into GE Vernova's transformation, financial health, and its pivotal role in the "New Energy" era. GE Vernova, spun off from General Electric in April 2024, is a pure-play energy titan focused on "electrifying and decarbonizing" to meet the demands of AI data centers, modernize aging grids, and achieve net-zero emissions. The company's business model encompasses power generation (gas, nuclear, hydro), wind energy, and electrification (grid solutions, power conversion, software), positioning it at the forefront of the global energy transition.

**2. Douglas Lane & Associates LLC Trims Stock Holdings in GE Vernova Inc. $GEV**
- Source: MarketBeat | 20251222T090623 | Somewhat-Bullish | Relevance: 100%
- Douglas Lane & Associates LLC recently reduced its stake in GE Vernova Inc. (NYSE:GEV) by 26.8% in the third quarter, now owning 10,193 shares valued at $6,268,000. Despite this reduction, other institutional investors like Norges Bank and Arrowstreet Capital Limited Partnership significantly increased their holdings. GE Vernova's stock has seen a 2.9% rise, trades at $658.03, and received several analyst upgrades, though some express neutral to negative sentiment regarding its valuation and recent performance.

**3. GE Vernova (GEV) Gets Higher Price Targets from Wells Fargo and UBS**
- Source: Finviz | 20251221T144856 | Bullish | Relevance: 100%
- Wells Fargo and UBS have both raised their price targets for GE Vernova (GEV) due to strong performance and optimistic outlooks for its Power and Electrification segments. Wells Fargo increased its price target from $717 to $831, citing higher EBITDA and EPS forecasts, while UBS raised its target from $760 to $835, believing the company's long-term guidance may be too cautious. Both firms maintain positive ratings, anticipating significant growth and higher margins for GE Vernova.

**4. Clarity Financial LLC Has $20.19 Million Holdings in GE Vernova Inc. $GEV**
- Source: MarketBeat | 20251221T090747 | Somewhat-Bullish | Relevance: 100%
- Clarity Financial LLC significantly trimmed its stake in GE Vernova Inc. (NYSE:GEV) by 29.2% in the third quarter, reducing its holdings to 32,840 shares valued at approximately $20.19 million. Despite this reduction, GE Vernova remains a substantial part of Clarity Financial's portfolio. The article also highlights recent positive analyst sentiment, with multiple firms issuing "buy" or "overweight" ratings and increasing price targets for GEV, alongside the company's financial performance including an EPS miss but a revenue beat and a dividend increase.

**5. Yousif Capital Management LLC Trims Stock Position in GE Vernova Inc. $GEV**
- Source: MarketBeat | 20251223T134604 | Somewhat-Bullish | Relevance: 100%
- Yousif Capital Management LLC reduced its stake in GE Vernova Inc. (NYSE:GEV) by 5.6% during the third quarter, selling 1,881 shares and retaining 31,748 shares valued at approximately $19.52 million. Analysts maintain a "Moderate Buy" consensus for GEV, with an average target price of $691.11, while the company recently increased its quarterly dividend to $0.50 and reported increased revenue. GE Vernova's stock opened at $661.03 on Tuesday, with a market cap of $179.35 billion.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | RBC Capital | $761 | $761 | 0% |
| 2025-12-22 | Jefferies | $830 | $815 | +2% |
| 2025-12-18 | Jefferies | $815 | $736 | +11% |
| 2025-12-17 | Goldman Sachs | $840 | $735 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | RBC Capital | main | Outperform |
| 2025-12-22 | Jefferies | main | Buy |
| 2025-12-18 | Jefferies | up | Buy |
| 2025-12-17 | Goldman Sachs | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (+0.6%)
- FMR, LLC: 8.4% (-8.5%)
- Blackrock Inc.: 7.4% (+1.8%)
- JPMORGAN CHASE & CO: 4.2% (+641.6%)
- State Street Corpora: 4.1% (+1.3%)

### Key Risks

1. High beta (2.67) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 10 raises (avg +9%) could attract flows.
- Momentum building: MRS_20 improving +1.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Forward P/E 49.8x attractive for 73% earnings growth. Analyst sentiment positive (10 raises, avg +9%). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $180.1B |
| Beta | 1.00 |
| 52W Range | $252.25 - $731.00 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 49.8 |
| Current P/E | 86.0 |
| YoY Growth | 72.6% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 0.9% to 2.5% (+1.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.5pp (needs >4.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. AM_20 at 3.6% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.59), momentum weakening. RSI neutral at 56. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.55% (CS: 78) | Neutral |
| RSI_14 | 55.6 | Neutral |
| MACD Histogram | -0.59 | Bearish |
| vs SMA20 | 1.036x | Above |
| vs SMA50 | 1.095x | Above |
| vs SMA200 | 1.257x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $660.33
- **Stop Loss:** $592.91 (10.2% risk)
- **Target:** $727.75 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 13
- **Position Value:** $8,584.29
- **Portfolio %:** 8.58%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-21 (Est: $3.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.86 | $1.64 | -11.7% |
| 2025Q2 | $1.63 | $1.86 | +14.3% |
| 2025Q1 | $0.61 | $0.91 | +49.1% |
| 2024Q4 | $2.49 | $1.73 | -30.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*